Efficacy News and Research

RSS
Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

Scientists detect delayed and reduced antibody responses after BioNTech/Pfizer COVID-19 vaccination in older adults

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

Nanobodies from nanomice and llamas show potent neutralizing activity against SARS-CoV-2 variants

Macrophages can aid tumor growth by distracting cancer-killing CD8+ T cells

Macrophages can aid tumor growth by distracting cancer-killing CD8+ T cells

In vivo protection from emerging SARS-CoV-2 variants by protein nanoparticle vaccine

In vivo protection from emerging SARS-CoV-2 variants by protein nanoparticle vaccine

Major anti-cancer protein released by neutrophils selectively kills tumor cells

Major anti-cancer protein released by neutrophils selectively kills tumor cells

ACTG launches phase 1 HIV cure study evaluating two promising therapies

ACTG launches phase 1 HIV cure study evaluating two promising therapies

The longevity of SARS-CoV-2 antibodies and their cross-neutralization against variants of concern

The longevity of SARS-CoV-2 antibodies and their cross-neutralization against variants of concern

Bovine-derived polyclonal antibodies exhibit high efficacy in neutralizing SARS-CoV-2 variants

Bovine-derived polyclonal antibodies exhibit high efficacy in neutralizing SARS-CoV-2 variants

Could the COVID-19 vaccination rollout protect against future coronavirus outbreaks?

Could the COVID-19 vaccination rollout protect against future coronavirus outbreaks?

Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants

Study reports on the immunogenicity of single-shot COVID-19 vaccine against SARS-CoV-2 variants

Trained dogs can accurately identify COVID-19 by scent

Trained dogs can accurately identify COVID-19 by scent

SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing

SARS-CoV-2 enzyme inhibitors among drugs screened for repurposing

Researchers review the therapeutic potential of resveratrol nasal formulations in COVID-19

Researchers review the therapeutic potential of resveratrol nasal formulations in COVID-19

What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?

What are the challenges of SARS-CoV-2 serosurveillance in COVID-19 vaccine recipients?

Microgel-coated mesenchymal stromal cells can reverse pulmonary fibrosis

Microgel-coated mesenchymal stromal cells can reverse pulmonary fibrosis

Potent antibody responses to BNT162b2 COVID-19 vaccine among Japanese healthcare workers

Potent antibody responses to BNT162b2 COVID-19 vaccine among Japanese healthcare workers

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

SARS-CoV-2 B.1.1.345 variant carrying E484K mutation detected in New York

ONK Therapeutics and Trinity researchers seek to improve cellular therapies for treating cancer

ONK Therapeutics and Trinity researchers seek to improve cellular therapies for treating cancer

SARS-CoV-2 immunity persists for up to 11 months after natural infection

SARS-CoV-2 immunity persists for up to 11 months after natural infection

The potential of mRNA vaccines for a wide range of diseases

The potential of mRNA vaccines for a wide range of diseases